Hemlibra “Now Approved and Available” Website for HCPs

Brand: Hemlibra (emicizumab-kxwh), Injection
Parent Company: Genentech
Drug Type: Boxed Warning
Drug Category: Hematology
Campaign: now-approved, Now Available
Targeting: HCPs
Patient Website: https://www.hemlibra.com/
HCP Website: https://www.hemlibra.com/hcp.html